FEN-YU TSENGTIEN-SHANG HUANGLin, Jen-DerJen-DerLinChen, Szu-TahSzu-TahChenWang, Pei-WenPei-WenWangChen, Jung-FuJung-FuChenHuey-Herng Sheu, WayneWayneHuey-Herng SheuTIEN-CHUN CHANGAcromegaly Registry Study Group2020-03-022020-03-022019-100929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/467691The objectives of this study were to describe epidemiological data, treatment outcomes, and quality of life (QOL) of patients with acromegaly in Taiwan.enAcromegaly; Health outcome; Patient registry; Quality of life; Taiwan[SDGs]SDG3angiopeptin; bromocriptine; cabergoline; dopamine receptor stimulating agent; glucose; growth hormone; hemoglobin A1c; high density lipoprotein cholesterol; low density lipoprotein cholesterol; octreotide; somatomedin C; somatostatin derivative; triacylglycerol; IGF1 protein, human; acromegaly; adult; amenorrhea; Article; asthenia; body weight gain; carpal tunnel syndrome; depression; female; follow up; galactorrhea; gynecomastia; headache; heart ventricle hypertrophy; human; hyperhidrosis; hypertension; hypopituitarism; macroadenoma; major clinical study; male; non insulin dependent diabetes mellitus; oily skin; oral glucose tolerance test; osteoarthritis; prevalence; quality of life; remission; sexual dysfunction; skinfold; sleep disordered breathing; snoring; Taiwan; thyroid disease; transsphenoidal surgery; treatment outcome; visual impairment; acromegaly; adenoma; blood; complication; galactorrhea; glucose blood level; growth hormone secreting adenoma; metabolism; middle aged; quality of life; register; young adult; Acromegaly; Adenoma; Adult; Blood Glucose; Female; Follow-Up Studies; Galactorrhea; Growth Hormone; Growth Hormone-Secreting Pituitary Adenoma; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Quality of Life; Registries; Taiwan; Young AdultA registry of acromegaly patients and one year following up in Taiwanjournal article10.1016/j.jfma.2018.12.017306128832-s2.0-85059423373WOS:000485819900008https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059423373&doi=10.1016%2fj.jfma.2018.12.017&partnerID=40&md5=5344c18c01acc97070f1a446f8eb37f5